Darling CEO plans $338K Rule 144 stock sale

Darling Ingredients, Inc. (DAR) has a notice from CEO and Chairman Randall C. Stuewe covering a proposed Rule 144 sale of 5,000 shares of common stock through J.P.

Rhea-AI Filing Summary

Darling Ingredients, Inc. (DAR) has a notice from CEO and Chairman Randall C. Stuewe covering a proposed Rule 144 sale of 5,000 shares of common stock through J.P. Morgan Securities LLC, with an aggregate market value of $338,500 and reference share count of 157,802,916 shares outstanding. The shares include 2,500 acquired via option exercise on March 4, 2024 and 2,500 from RSUs on March 5, 2024. Stuewe also reported prior sales of 5,000 shares on July 12, 2026 and 5,000 shares on July 13, 2026.

Key Figures

Proposed shares to be sold: 5,000 shares Aggregate market value of proposed sale: $338,500 Shares outstanding: 157,802,916 shares +5 more

8 metrics

Proposed shares to be sold 5,000 shares Common stock covered by Rule 144 notice through J.P. Morgan Securities LLC

Aggregate market value of proposed sale $338,500 Market value of 5,000 shares of common stock referenced in the notice

Shares outstanding 157,802,916 shares Common shares outstanding referenced in the notice

Shares from option exercise 2,500 shares Acquired March 4, 2024 via option exercise from issuer as compensation

Shares from RSUs 2,500 shares Acquired March 5, 2024 via RSUs from issuer as compensation

Prior sale July 12, 2026 5,000 shares for $315,968.48 Common stock sold by Randall Stuewe during past 3 months

Prior sale July 13, 2026 5,000 shares for $323,659.82 Common stock sold by Randall Stuewe during past 3 months

Proposed sale date reference September 2, 2026 Date associated with proposed sale of 5,000 shares on NYSE

Key Terms

Rule 144, Option Exercise, RSUs

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Option Exercise financial

"Common Stock | 03/04/2024 | Option Exercise | Issuer"

RSUs financial

"Common Stock | 03/05/2024 | RSUs | Issuer"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Darling Ingredients (DAR) shares are proposed to be sold under this Rule 144 notice?

The notice covers a proposed sale of 5,000 shares of Darling Ingredients common stock through J.P. Morgan Securities LLC, with an indicated aggregate market value of $338,500 and a reference of 157,802,916 shares outstanding.

Who is selling Darling Ingredients (DAR) shares and through which broker?

The seller is Randall C. Stuewe, CEO and Chairman of Darling Ingredients, with J.P. Morgan Securities LLC acting as agent and attorney-in-fact for the proposed sale of 5,000 shares of common stock.

When were the DAR shares to be sold under Rule 144 acquired?

Of the 5,000 shares covered by the notice, 2,500 shares were acquired via option exercise on March 4, 2024, and 2,500 shares were acquired as RSUs on March 5, 2024, both from the issuer as compensation.

What is the proposed sale date for the 5,000 Darling Ingredients (DAR) shares?

The proposed sale of 5,000 shares of Darling Ingredients common stock is referenced with a date of September 2, 2026, and the shares are listed on the NYSE.

What prior Darling Ingredients (DAR) share sales by Randall C. Stuewe are disclosed?

The notice lists prior sales of 5,000 shares of common stock on July 12, 2026 for $315,968.48 and another 5,000 shares on July 13, 2026 for $323,659.82.

How many Darling Ingredients (DAR) shares are referenced as outstanding in this notice?

The notice references 157,802,916 shares of Darling Ingredients common stock as outstanding, which serves as a baseline figure and not the amount proposed to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:47 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:46 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001256109
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Darling Ingredients, Inc.
SEC File Number	001-13323
Address of Issuer	5601 N. MacArthur Blvd Irving TEXAS 75038
Phone	972-717-0300
Name of Person for Whose Account the Securities are To Be Sold	Randall C. Stuewe
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO
Relationship to Issuer	Chairman

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	5000	338500	157802916	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/04/2024	Option Exercise	Issuer			2500	03/04/2024	Compensation
Common Stock	03/05/2024	RSUs	Issuer			2500	03/05/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Randall Stuewe C/o Issuer 5601 N. MacArthur Blvd Irving TX 75038	Common Stock	07/12/2026	5000	315968.48
Randall Stuewe C/o Issuer 5601 N. MacArthur Blvd Irving TX 75038	Common Stock	07/13/2026	5000	323659.82

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Randall C. Stuewe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)